article Open AccessTop 1% cited
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
Clinical Infectious Diseases · 2019 · Vol. 71(6) · pp. 1367–1376
J. Peter Donnelly✉(Radboud University Medical Center)Sharon Chen(The University of Sydney)Carol A. Kauffman(University of Michigan)William J. Steinbach(Duke Medical Center)John W. Baddley(University of Alabama at Birmingham)Paul E. Verweij(Radboud University Medical Center)Cornelius J. Clancy(University of Pittsburgh)John R. Wingard(Florida College)Shawn R. Lockhart(Centers for Disease Control and Prevention)Andreas H. Groll(University Hospital Münster)Tania C. Sorrell(Westmead Institute)Matteo Bassetti(University of Genoa)Hamdi Akan(Ankara University)Barbara D. Alexander(Duke Medical Center)David R. Andes(University of Wisconsin–Madison)Élie Azoulay(Hôpital Saint-Louis)Ralf BialekRobert W. Bradsher(University of Arkansas for Medical Sciences)Stéphane Bretagne(Université Paris Cité)Thierry Calandra(University of Lausanne)Angela M. Caliendo(Brown University)Elio Castagnola(Istituti di Ricovero e Cura a Carattere Scientifico)Mario CrucianiManuel Cuenca‐Estrella(Instituto de Salud Carlos III)Catherine F. Decker(Uniformed Services University of the Health Sciences)Sujal R. Desai(Royal Brompton & Harefield NHS Foundation Trust)Brian T. Fisher(Children's Hospital of Philadelphia)Thomas S. Harrison(St George's, University of London)Claus Peter Heußel(Heidelberg University)Henrik Elvang Jensen(University of Copenhagen)Christopher C. Kibbler(University College London)Dimitrios P. Kontoyiannis(The University of Texas MD Anderson Cancer Center)Bart Jan Kullberg(Radboud University Nijmegen)Katrien Lagrou(KU Leuven)Frédéric Lamoth(University of Lausanne)Thomas Lehrnbecher(University Hospital Frankfurt)Jürgen Loeffler(Universitätsklinikum Würzburg)Olivier Lortholary(Centre National de la Recherche Scientifique)Johan Maertens(KU Leuven)Oscar Marchetti(University of Lausanne)Kieren A. Marr(Johns Hopkins Medicine)Henry Masur(National Institutes of Health Clinical Center)Jacques F. Meis(Radboud University Medical Center)C Orla Morrisey(Alfred Health)Márcio Nucci(Universidade Federal do Rio de Janeiro)Luis Ostrosky‐ZeichnerLivio Pagano(Università Cattolica del Sacro Cuore)Thomas F. Patterson(South Texas Veterans Health Care System)John R. Perfect(Duke Medical Center)Zdeněk Ráčil(University Hospital Brno)Emmanuel Roilides(Hippocration General Hospital)Marcus Ruhnke(Lukaskrankenhaus)Cornelia Schaefer Prokop(Meander Medisch Centrum)Shmuel Shoham(Johns Hopkins University)Monica A. Slavin(Peter MacCallum Cancer Centre)David A. Stevens(California Institute for Medical Research)George R. Thompson(University of California Davis Medical Center)José A. Vázquez(Augusta University)Claudio Viscoli(Ospedale Policlinico San Martino)Thomas J. Walsh(Cornell University)Adilia Warris(University of Aberdeen)L. Joseph WheatP. Lewis White(University Hospital of Wales)Theoklis E. Zaoutis(Children's Hospital of Philadelphia)Peter G. Pappas(University of Alabama at Birmingham)
Abstract
These updated definitions of IFDs should prove applicable in clinical, diagnostic, and epidemiologic research of a broader range of patients at high-risk.
Antifungal resistance and susceptibilityFungal Infections and StudiesInfectious Diseases and MycologyMedicineFungal diseaseConsensus conferenceCancerClinical researchDiseaseFamily medicinePathologyInternal medicineDermatology
MeSH terms
Invasive Fungal InfectionsAntifungal AgentsHumansMycosesNeoplasmsImmunocompromised HostConsensus
Funding
- Pfizer
- Gilead Sciences
- Alexion Pharmaceuticals
- Cidara Therapeutics
- Ablynx
- Amplyx
- Astellas Pharma
- Deutsches Zentrum für Lungenforschung
- Swedish Orphan Biovitrum
- National Institutes of Health
- Centers for Disease Control and Prevention
- MSD Australia
- Medical Research Council
Citations
2,680
FWCI
148.18
field-weighted impact
References
83
Percentile
100%
vs. same field & year
Citations per year
Cited by
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
The Lancet Infectious Diseases · 2020 · 928 citations
References
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database
Clinical Infectious Diseases · 2010 · 1,422 citations
Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)
Clinical Infectious Diseases · 2010 · 1,528 citations
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Clinical Infectious Diseases · 2008 · 4,889 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.